Pharmacovigilence professionals gain insight to (EU) 2017/745 for increased compliance and operational excellence.
London, UK — Qinecsa Solutions (Qinecsa), specialists in technology-led end-to-end pharmacovigilance solutions, will present an in-depth exploration of medical device regulations, for pharmacovigilance professionals seeking mastery in compliance and operational excellence.
Industry expert, Veronika Valdova, will guide participants through key regulatory requirements, integration challenges, and actionable steps for building resilient processes to support combined drug and device portfolios within primarily pharma-focused organizations.
This presentation will provide a unique opportunity to consider the knowledge and tools necessary to navigate the complex EU device vigilance regulatory landscape, appreciate the obligations of individual entities in the device lifecycle compared to medicinal products, understand the conceptual differences in drug and device surveillance requirements, and confidently adapt their department to the change.
Participants will come away with a greater understanding of:
Taking place as an hour-long webinar session on Wednesday 17 April, participants can join one of three sessions at 11am, 3pm and 7pm BST.
For more information on the free to attend webinar and to register, click here: https://bit.ly/43Qmedr
To connect with Qinecsa, visit www.qinecsa.com
About Qinecsa Solutions
Qinecsa are specialists in technology led end-to-end pharmacovigilance solutions. We are trusted, global partners bringing together best-in-class technology and scientific expertise to connect life science companies to the right safety solutions. Through our unique insight into the challenges of pharmacovigilance, we have created industry-leading, end-to-end solutions for capturing, managing, and evaluating drug safety data, more efficiently and accurately. Working with life science companies we drive progress to continue protecting lives.
For more information visit: www.qinecsa.com
Media Enquiry: Sophie Beattie, +44 7494 129339, Sophie@discovery-pr.com
Forging the Next 250 Years: Powering the Next Era of American Manufacturing
Brooklyn Army Terminal (BAT) began as a World War II-era military supply base. Today it is New York City’s largest publicly owned industrial campus, with 59 waterfront acres, more than 4 million square feet and over 100 businesses. In this episode of Industry Insights, Bridget Chansakul, Vice President of Leasing & Portfolio Management at NYCEDC, explains what space is available and what’s planned for the 250,000+ square feet of new industrial space in Building A. She also covers how the ferry, parking and on-site childcare help tenants hire and keep workers, along with workforce partnerships, City incentives for manufacturers and where BAT is headed next.
Get In Touch
Google news and SEO compliant, Industry Today’s state-of-the-art digital media platform offers bespoke media campaigns that target key decision makers and buyers to achieve your marketing and promotional goals.
Contribute
Showcase your brand and promote your business to our highly targeted audience. We offer detailed Google Analytics with measurable ROI to assure success. Submit your content for review by our Editorial team who will contact you to discuss the project further.
About Us
Reach Your Targeted Audience and Grow Your Business. Learn more About Industry Today.
Contact Us
© 2026 Industry today. All Rights reserved.
